Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$875,583
+$204,151 QoQ
Shares Held
730
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#3,267
of 4,621 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sage Capital Management, LLC holds $2,235,834 across 3 Drug Manufacturers - General names. LLY ranks #2 (39.2% of the industry book) .
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $875,583 | 730 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $671,432 | 730 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $783,441 | 729 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $556,227 | 729 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $568,277 | 729 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $600,436 | 727 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $682,448 | 884 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $906,316 | 1,023 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $926,203 | 1,023 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $845,642 | 1,087 | Shares | Sole | 2024-07-31 | |
| 2023-12-31 | $633,634 | 1,087 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||